title: Susceptibility to Plasmodium berghei infection in rats is modulated by the acute phase response.
abstract: Brown Norway (BN) and Sprague Dawley (SD) rats are known to differ in their susceptibility to infection with sporozoites of Plasmodium berghei, as measured by the density of liver schizonts. Because of the known inhibitory effect of non-specific immunomodulators on schizont development, we compared some aspects of the acute phase response in these two rat strains. LPS induced IL-6 production was measured in supernatants of spleen cells and peritoneal macrophages of both strains. SD rats, which are the least susceptible to P. berghei sporozoites, showed significantly higher IL-6 production by macrophages from both sources. When LPS was administered in vivo, SD rats also had a significantly higher IL-6 response. Hepatocytes from both strains were cultured in the presence of IL-6. After three days of culture, alpha 2-Macroglobulin concentrations in the supernatants of SD hepatocytes were much higher than those from BN rats. Kupffer cell depletion in both BN and SD rats was correlated with a significant increase in liver schizont density, but did not abrogate the difference in susceptibility. From these results we conclude that the higher cytokine production capacity of SD rats compared to BN rats, may contribute to the difference in susceptibility to P. berghei sporozoites between these strains, but that other yet unknown factors are also involved.
authors.affiliation: Department of Medical Microbiology, University Hospital Nijmegen, The Netherlands.
authors.forename: S G
authors.initials: SG
authors.lastname: Vreden
authors.forename: M F
authors.initials: MF
authors.lastname: Van den Broek
authors.forename: M C
authors.initials: MC
authors.lastname: Oettinger
authors.forename: W
authors.initials: W
authors.lastname: Boers
authors.forename: N
authors.initials: N
authors.lastname: Van-Rooijen
authors.forename: J H
authors.initials: JH
authors.lastname: Meuwissen
authors.forename: R W
authors.initials: RW
authors.lastname: Sauerwein
mesh_terms: D000209:Acute-Phase Proteins / Q000494:pharmacology; D000210:Acute-Phase Reaction; D000818:Animals; D002478:Cells, Cultured; D004198:Disease Susceptibility; D015850:Interleukin-6 / Q000096:biosynthesis* / Q000494:pharmacology; D007728:Kupffer Cells / Q000276:immunology; D008070:Lipopolysaccharides; D008099:Liver / Q000166:cytology / Q000469:parasitology; D017737:Macrophages, Peritoneal / Q000276:immunology; D008288:Malaria / Q000276:immunology* / Q000469:parasitology; D008297:Male; D010962:Plasmodium berghei / Q000254:growth & development / Q000276:immunology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D000511:alpha-Macroglobulins / Q000096:biosynthesis / Q000494:pharmacology
chemical_list: D000209:Acute-Phase Proteins; D015850:Interleukin-6; D008070:Lipopolysaccharides; D000511:alpha-Macroglobulins